Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac Sells 58,212 Shares of Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 58,212 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $10.33, for a total transaction of $601,329.96. Following the completion of the sale, the chief executive officer now directly owns 10,020,588 shares of the company’s stock, valued at $103,512,674.04. This represents a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

K Charles Janac also recently made the following trade(s):

  • On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The shares were sold at an average price of $10.42, for a total transaction of $631,285.28.
  • On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
  • On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The shares were sold at an average price of $10.12, for a total value of $180,702.72.
  • On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The stock was sold at an average price of $8.58, for a total value of $10,656.36.

Arteris Trading Up 16.7 %

Shares of AIP stock opened at $11.89 on Friday. Arteris, Inc. has a fifty-two week low of $4.83 and a fifty-two week high of $11.90. The stock’s fifty day moving average price is $8.79 and its two-hundred day moving average price is $8.03. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The company has a market cap of $477.70 million, a PE ratio of -12.39 and a beta of 1.25.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 price objective on shares of Arteris in a research report on Wednesday, November 6th.

View Our Latest Analysis on AIP

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. lifted its holdings in shares of Arteris by 67.1% in the third quarter. JPMorgan Chase & Co. now owns 92,242 shares of the company’s stock worth $712,000 after acquiring an additional 37,032 shares during the last quarter. Franklin Resources Inc. increased its position in Arteris by 0.8% during the 3rd quarter. Franklin Resources Inc. now owns 1,491,415 shares of the company’s stock worth $11,201,000 after purchasing an additional 12,375 shares in the last quarter. Barclays PLC lifted its stake in Arteris by 321.1% in the 3rd quarter. Barclays PLC now owns 39,396 shares of the company’s stock valued at $304,000 after purchasing an additional 30,041 shares during the last quarter. Geode Capital Management LLC boosted its position in Arteris by 6.6% in the third quarter. Geode Capital Management LLC now owns 597,116 shares of the company’s stock valued at $4,610,000 after buying an additional 36,908 shares in the last quarter. Finally, State Street Corp grew its stake in shares of Arteris by 18.5% during the third quarter. State Street Corp now owns 410,578 shares of the company’s stock worth $3,170,000 after buying an additional 64,081 shares during the last quarter. Institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.